copper(II) tetrakis(4-methyloxyphenyl)porphyrin

Copper(II) tetrakis(4-methyloxyphenyl)porphyrin is an academic-stage **small molecule** copper metalloporphyrin that has been reported as a potential **anticancer** research compound. It was synthesized as part of a series of copper porphyrin derivatives and evaluated preclinically against **MCF-7 breast cancer cells**, where it showed the strongest cytotoxic activity within that series, with a reported IC50 of 32.07 \u03bcg/mL. The compound was prepared using the Adler-Longo porphyrin synthesis approach and characterized by elemental analysis, mass spectrometry, FT-IR, and related spectroscopic methods. No validated molecular target or clinically established mechanism of action has been identified from the provided evidence; its antitumor activity is currently best described as exploratory cytotoxic activity of a copper porphyrin complex in early preclinical research led by investigators at Thammasat University and collaborating academic institutions in Thailand.

Other names

copper(II) tetrakis(4-methyloxyphenyl)porphyrinCuTOMPP